(HealthDay)—The first symptoms of throat and mouth cancer—also known as oropharyngeal cancer—may differ depending on whether the condition is caused by the human papillomavirus (HPV), a small study suggests.
Mar 20, 2014
0
0
Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London.
Oct 1, 2013
0
0
(HealthDay)—Graphic ads depicting the ravages of smoking have generated a bigger than expected response, federal health officials said Thursday.
Sep 19, 2013
0
0
American and European research shows an alarming increase in the rate of tonsillar cancer related to the human papilloma virus (HPV), a sexually transmitted virus. Experts suggest a similar trend has emerged in Canada, but ...
Aug 13, 2013
0
0
Improving vaccination rates against the human papillomavirus (HPV) in boys is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty ...
Jul 22, 2013
0
0
Spouses and long-term partners of patients with mouth and throat cancers related to infection with the human papilloma virus (HPV) appear to have no increased prevalence of oral HPV infections, according to results of a multicenter, ...
Jun 1, 2013
0
0
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, according ...
Mar 28, 2013
0
0
A recent study from the American Cancer Society purports that heavy coffee drinkers may reduce the risk of dying from mouth and throat cancer by half, but one dentist is not raising a coffee cup in support.
Dec 18, 2012
0
0
(HealthDay)—A frank and graphic nationwide media campaign to motivate smokers to quit seems to be working, say researchers at the U.S. Centers for Disease Control and Prevention.
Nov 8, 2012
0
0
(Medical Xpress)—A new test designed to classify tonsil and throat cancers into one of two groups should help deliver the right treatment to the right patients, according to research being presented at the NCRI Cancer Conference ...
Nov 5, 2012
0
0
